Perigon Wealth Management, LLC Novavax Inc Transaction History

Perigon Wealth Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$36.28 - $75.29 $146,607 - $304,246	-4,041 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $8,367 - $17,148	120 Added 3.06%	4,041 $298,000
Q4 2021 Feb 11, 2022	BUY	$134.56 - $217.97 $403 - $653	3 Added 0.08%	3,921 $561,000
Q3 2021 Nov 01, 2021	BUY	$177.8 - $270.58 $696,620 - $1.06 Million	3,918 New	3,918 $812,000
Q3 2021 Oct 25, 2021	SELL	$177.8 - $270.58 $694,664 - $1.06 Million	-3,907 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$121.0 - $257.67 $48,158 - $102,552	-398 Reduced 9.25%	3,907 $829,000
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $45,304 - $128,291	-401 Reduced 8.52%	4,305 $781,000
Q4 2020 Jan 28, 2021	BUY	$78.74 - $139.5 $307,086 - $544,050	3,900 Added 483.87%	4,706 $525,000
Q3 2020 Nov 03, 2020	BUY	$79.44 - $178.51 $476 - $1,071	6 Added 0.75%	806 $87,000
Q2 2020 Jul 29, 2020	BUY	$13.86 - $83.61 $11,088 - $66,888	800 New	800 $67,000

284

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $731M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Perigon Wealth Management, LLC with notifications on news.